Agalaia Therapeutics raised €4.0M in a Seed round in Sep 2021. The company is based in Paris, France. Investors in the round: Advent France Biotechnology, Crédit Mutuel Innovation, Pierre Fabre. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €4.0M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
